A New Calcipotriol/Betamethasone Dipropionate Formulation (DaivobetTM) Is an Effective Once-Daily Treatment for Psoriasis vulgaris

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Dermatology

• Publication date

  2002-12-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000066440PMID 12444337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis.

  2003cited by this paper
• A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.

  2002cited by this paper
• Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy

  1998cited by this paper
• Compatibility of calcipotriene with other topical medications.

  1998cited by this paper
• Frequency of application of topical corticosteroids: an overview

  1998cited by this paper
• Current experience with tacalcitol ointment in the treatment of psoriasis.

  1998cited by this paper
• Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double‐blind, randomized study

  1998cited by this paper
• Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.

  1996cited by this paper
• Psoriasis in the community: prevalence, severity and patients' beliefs and attitudes towards the disease

  1996cited by this paper
• Comparison of fluticasone propionate ointment, 0.005%, and betamethasone-17,21-dipropionate ointment, 0.05%, in the treatment of psoriasis.

  1996cited by this paper
• A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.

  1996cited by this paper
• The effect of severe psoriasis on the quality of life of 369 patients

  1995cited by this paper
• Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.

  1993cited by this paper
• A multicentre, parallel‐group comparison of calcipotriol ointment and short‐contact dithranol therapy in chronic plaque psoriasis

  1992cited by this paper
• Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris.

  1992cited by this paper
• Clinical efficacy and safety of augmented betamethasone dipropionate ointment and diflorasone diacetate ointment for psoriasis - a multicentre, randomized, double-blinded study

  1991cited by this paper
• Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.

  1991cited by this paper
• Possible dosage regimens for topical steroids, assessed by vasoconstrictor assays using multiple applications.

  1983cited by this paper
• Treatment of psoriasis.

  1976cited by this paper
• Treatment of Psoriasis

  1873cited by this paper

• Expert recommendations on topical therapy for psoriasis from the Spanish Psoriasis Working Group (GPS).

  2025cites this paper
• Calcipotriol in the treatment of various dermatoses.

  2025cites this paper
• Tratamiento tópico de la psoriasis: recomendaciones de expertos del Grupo Español de Psoriasis (GPS).

  2025cites this paper
• Calcipotriol/Betamethasone Dipropionate for the Treatment of Psoriasis: Mechanism of Action and Evidence of Efficacy and Safety versus Topical Corticosteroids

  2024cites this paper
• Current status and evidence gap map of betamethasone-loaded nanostructured formulations as cutaneous delivery systems: A scoping review.

  2024cites this paper
• Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies

  2023cites this paper
• Patient preferences for topical psoriasis treatments: a discrete choice experiment

  2022cites this paper
• Calcipotriol/Betamethasone Dipropionate Foam Inhibits Th17 Cytokine Secretion and Improves Epidermal Barrier Markers in a Human Th17 Skin Inflammation Model

  2021cites this paper
• Topical calcipotriol plus betamethasone dipropionate for the treatment of plaque psoriasis: a drug evaluation

  2021cites this paper
• Topical Vitamin D3

  2021cites this paper
• Therapeutic alternative for oral lichen planus treatment in an unusual location: case report

  2021cites this paper
• Innovations in Psoriasis Management: Based on Selected Presentations from the Symposium for Cosmetic Advances & Laser Education (SCALE) Virtual Congress-July 24 to 26, 2020.

  2020cites this paper
• Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis

  2020cites this paper
• Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data

  2020cites this paper
• Topical Psoriasis Therapy. Part I

  2020cites this paper
• Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study

  2020cites this paper
• Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology

  2019cites this paper
• R esults of the long-term observational non-interventional prospective study BODYGUARD in psoriasis patients

  2019cites this paper
• Results of the long-term observational noninterventional prospective study BODYGUARD in psoriasis patients

  2019cites this paper
• Calcipotriol and betamethasone dipropionate exhibit different immunomodulatory effects on imiquimod‐induced murine psoriasiform dermatitis

  2019cites this paper
• Calcipotriol and betamethasone dipropionate synergistically enhances the balance between regulatory and proinflammatory T cells in a murine psoriasis model

  2019cites this paper
• Therapeutic Class Overview Antipsoriatic Agents

  2019cites this paper
• Therapeutic equivalence of two formulations of calcipotriol–betamethasone ointment: a multicentre, randomized, double‐blind study in adult patients with chronic plaque psoriasis

  2018cites this paper
• An Evidence Based Approach of Use of Topical Corticosteroids in Dermatology

  2018cites this paper
• Efficacy and safety of agents containing betamethasone dipropionate and calcipotriol in topical therapy of psoriasis

  2018cites this paper
• High Sensitive Voltammetric Determination of Betamethasone on an Amalgam Film Electrode

  2018cites this paper
• Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.

  2017cites this paper
• REVISIÓN An Update on Scalp Psoriasis

  2017cites this paper
• Topical corticosteroids or vitamin D analogues for plaque psoriasis?

  2017cites this paper
• Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review

  2017cites this paper
• Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2017 MauiDerm Meeting.

  2017cites this paper
• The cost-effectiveness of blue-light therapy in the treatment of mild-to-moderate psoriasis.

  2017cites this paper
• Topical Therapies in Psoriasis

  2017cites this paper
• Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: A targeted approach for psoriasis management.

  2017cites this paper
• Disease Assessment and Classifi cation 6 Topical Treatments for Psoriasis 11 Medication Adherence : The Crucial Factor for Successful Treatment 12 Investigational Treatments 14 Post-Test and Evaluation Form Topical Therapies for Psoriasis : Improving Management Strategies and Patient Adherence Table

  2016cites this paper
• Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

  2016cites this paper
• Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.

  2016cites this paper
• Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence.

  2016cites this paper
• Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population

  2016cites this paper
• Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review

  2016influential citation
• Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis

  2016cites this paper
• Comparative safety of topical calcipotriol (0.005%) versus topical corticosteroid (betamethasone 0.1%) in plaque type psoriasis

  2016cites this paper
• THE TREATMENT OF PSORIASIS – APPROACHES AND ADVANTAGES

  2016cites this paper
• Patient-reported Outcomes: Association with Clinical Response to Psoriasis Therapies

  2016cites this paper
• Calcipotriol/betamethasone for the treatment of psoriasis: efficacy, safety, and patient acceptability

  2015cites this paper
• Evolution of Topical Therapy in the Treatment of Psoriasis: A Review

  2015cites this paper
• Efficacy of topical Calcipotriol versus combination of topical Calcipotriol plus Betamethasone in the treatment of plaque type psoriasis

  2015cites this paper
• Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.

  2015cites this paper
• Evaluation of change in the skin concentration of tazarotene and betamethasone dipropionate based on drug–drug interaction for transdermal drug delivery in miniature pig

  2015cites this paper
• 日本人尋常性乾癬患者における活性型ビタミンD3/ ステロイド配合外用薬（ドボベット®軟膏）の有効性 ─国内第III相試験のサブ解析─

  2015cites this paper
• Effects of Rusanda Spa balneotherapy combined with calcipotriol on plaque psoriasis.

  2015cites this paper
• Comparative Efficacy of Topical Calcipotriol (0.005%) Versus Topical Corticosteroid (Betamethasone 0.1%) in Treating Plaque Type Psoriasis

  2015cites this paper
• Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis

  2014cites this paper
• Topische Therapie von entzündlichen Dermatosen, Juckreiz und Schmerz sowie Hyperhidrose

  2014cites this paper
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014cites this paper
• Combination therapy using maxacalcitol and corticosteroid lotions preliminary to monotherapy with maxacalcitol lotion for scalp psoriasis

  2014cites this paper
• Managing Moderate-to-Severe Psoriasis in the Elderly

  2014cites this paper
• Therapeutic implications of the circadian clock on skin function.

  2014cites this paper
• Calcipotriol/betamethasone dipropionate ointment in mild‐to‐moderate paediatric psoriasis: long‐term daily clinical practice data in a prospective cohort

  2014cites this paper
• Comparative Bioequivalence Study of Two Marketed Formulation of Betamethasone Injectable Suspensions

  2013cites this paper
• Adherencia y satisfacción del paciente y características organolépticas y de uso de los tratamientos tópicos utilizados para la psoriasis: Consenso Delphi del panel de expertos y miembros del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología

  2013cites this paper
• Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: A double-blind, randomized, comparative study

  2013cites this paper
• Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology.

  2013cites this paper
• Betamethasone valerate dressing is non-inferior to calcipotriol–betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial

  2013cites this paper
• Topical therapies for the treatment of plaque psoriasis: systematic review and network meta‐analyses

  2013cites this paper
• Praktikabilität der kombinierten Anwendung von Calcipotriol/Betamethason in Gel‐Form (Daivobet® Gel) und Verbesserung der Lebensqualität bei Patienten mit Psoriasis vulgaris

  2013cites this paper
• Use of a psoriasis plaque test in the development of a gel formulation of calcipotriol and betamethasone dipropionate for scalp psoriasis

  2013cites this paper
• Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost‐effectiveness analysis

  2013cites this paper
• Efficacy and safety of combinations of first‐line topical treatments in chronic plaque psoriasis: a systematic literature review

  2013cites this paper
• Practicability of combined treatment with calcipotriol/betamethasone gel (Daivobet® Gel) and improvement of quality of life in patients with psoriasis

  2013cites this paper
• Adherence and Patient Satisfaction With Topical Treatment in Psoriasis, and the Use, and Organoleptic Properties of Such Treatments: A Delphi Study With an Expert Panel and Members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology

  2013cites this paper
• Emerging topical treatments for psoriasis

  2013cites this paper
• Topical treatments for chronic plaque psoriasis.

  2013cites this paper
• Adherence to topical treatment in psoriasis: a systematic literature review

  2012cites this paper
• Calcipotriene foam, 0.005% in mild-to-moderate plaque psoriasis

  2012cites this paper
• Comparison of the Antipsoriatic Effect and Tolerability of Calcipotriol-Containing Products in the Treatment of Psoriasis Vulgaris Using a Modified Psoriasis Plaque Test

  2012cites this paper
• German S3-guidelines on the treatment of psoriasis vulgaris (short version) A. NastW. H. BoehnckeU. MrowietzH. M. OckenfelsS. PhilippK. ReichT. Rosenbach • A. SammainM. SchlaegerM. SebastianW. SterryV. StreitM. AugustinR. ErdmannJ. Klaus •

  2012cites this paper
• S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

  2012cites this paper
• Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.

  2012cites this paper
• Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

  2012cites this paper
• Combination treatments for psoriasis: a systematic review and meta-analysis.

  2012cites this paper
• Managing psoriasis: what's best for your patient?

  2012cites this paper
• Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation

  2012cites this paper
• Comparison of the Antipsoriatic Effect and Tolerability of Calcipotriol-Containing Products in the Treatment of Psoriasis Vulgaris Using a Modified Psoriasis Plaque Test

  2012cites this paper
• Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities

  2012cites this paper
• German S3-guidelines on the treatment of psoriasis vulgaris (short version)

  2012cites this paper
• Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review

  2012cites this paper
• A patient decision aid for psoriasis based on current clinical practice guidelines.

  2012cites this paper
• What is new in topical therapy for psoriasis?

  2011cites this paper
• S3 – Guidelines on the treatment of psoriasis vulgaris Update 2011

  2011cites this paper
• Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation

  2011cites this paper
• The Role of Vitamin D in Psoriasis

  2011cites this paper
• Psoriasis: A comprehensive review

  2011cites this paper
• S3‐Leitlinie zur Therapie der Psoriasis vulgaris Update 2011

  2011cites this paper
• Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions.

  2011cites this paper
• Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris

  2011cites this paper
• The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis – an introduction

  2011cites this paper
• Evaluating Psoriasis: A Review of the Assessments Most Commonly Used in Clinical Trials

  2011cites this paper
• Spotlight on Calcipotriene/Betamethasone Dipropionate in Psoriasis Vulgaris of the Trunk, Limbs, and Scalp

  2011cites this paper
• Calcipotriol/Betamethasone Dipropionate

  2011influential citation